Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of “Moderate Buy” from Brokerages

Stevanato Group S.p.A. (NYSE:STVN) has been given an average rating of “Moderate Buy” by the six ratings firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company.

Several equities research analysts have commented on STVN shares. Wolfe Research initiated coverage on shares of Stevanato Group in a report on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target on the stock. Bank of America raised their target price on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a report on Friday, December 13th. Finally, Morgan Stanley restated an “equal weight” rating and issued a $23.00 price objective (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. nVerses Capital LLC acquired a new position in Stevanato Group during the third quarter worth $84,000. Hardy Reed LLC increased its stake in shares of Stevanato Group by 8.2% during the third quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after purchasing an additional 840 shares in the last quarter. Lindenwold Advisors INC lifted its stake in Stevanato Group by 13.5% in the 3rd quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock valued at $239,000 after buying an additional 1,415 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in Stevanato Group by 59.2% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock worth $219,000 after buying an additional 4,441 shares during the last quarter. Finally, Raymond James Trust N.A. increased its stake in Stevanato Group by 22.6% during the 3rd quarter. Raymond James Trust N.A. now owns 12,556 shares of the company’s stock worth $251,000 after buying an additional 2,317 shares in the last quarter.

Stevanato Group Trading Down 4.5 %

Shares of NYSE:STVN opened at €21.90 ($22.58) on Tuesday. The business has a 50-day moving average price of €21.29 and a 200-day moving average price of €20.27. The stock has a market cap of $6.47 billion, a price-to-earnings ratio of 46.60, a PEG ratio of 10.49 and a beta of 0.56. Stevanato Group has a 52-week low of €16.56 ($17.07) and a 52-week high of €34.73 ($35.80). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.12) EPS for the quarter, missing the consensus estimate of €0.13 ($0.13) by (€0.01) (($0.01)). The business had revenue of €277.90 million for the quarter, compared to analyst estimates of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.16 earnings per share. Equities analysts predict that Stevanato Group will post 0.5 EPS for the current year.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.